First-in-human clinical trial to test CAR T cell therapy for pediatric gliomas
The Phase 1 clinical trial is expected to enroll up to 18 children between 4 and 18 years old with pediatric high-grade gliomas.
Posts tagged as
Pediatric Cancer
John Ligon, M.D., receives grant to study disparities in pediatric cancer clinical trials
The project will study the impact of race and ethnicity on immunotherapy outcomes in children and adolescent young adult patients with cancer.
